Efficacy of palifermin in the treatment of oral mucositis in non-hematopoietic stem cell transplant pediatric patients: experience of a single tertiary hospital
Palifermin is safe and well tolerated and shows some effect in non-hematopoietic stem cell transplant pediatric patients with severe oral mucositis post-intensified chemotherapy or radiation therapy.
Authors
- Nawaf Alkhayat
- Bodour Elhussein
- Amal Binhassan
- Hasna Hamzi
- Yasser Elborai (ORCID: https://orcid.org/0000-0002-5528-0025)
- Omar Alsharif (ORCID: https://orcid.org/0000-0002-7511-9538)
- Mohammad Alshahrani (ORCID: https://orcid.org/0000-0001-9048-1386)
- Ebtsam Alhariri
- A Alenazi
- Sami Nawaf Mohammed Alsharif
- Amal Najmeldin
- Nour Althibani
Institutions
- Riyadh Armed Forces Hospital (SA)
- Prince Mohammed bin Abdulaziz Hospital (SA)
- Children Cancer Hospital (EG)
Publication Details
- Journal
- Journal of the Egyptian National Cancer Institute
- Published
- 2024-12-02
- DOI
- https://doi.org/10.1186/s43046-024-00247-x
- Primary Topic
- Oral health in cancer treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00